Allergic asthma
Trovati 26 articoli
- Wheezing after early-life antibiotics
- Children who are given antibiotics in their first three months often wheeze at 15 months of age. However, this wheezing is probably more due to the presence of chest infections than to the use of antibiotics. These were the key findings of research carried out by Researchers in New Zealand. Th... (Leggi Articolo)
- Montelukast and possible risk of suicide
- The FDA ( Food and Drug Administration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) and suicide. Singulair is a medicine in the drug class known as leukotriene receptor antagoni... (Leggi Articolo)
- Singulair: possible association with behavior/mood changes, suicidality and suicide
- The FDA ( Food and Drug Adminsitration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) and suicide. Singulair is a medicine in the drug class known as leukotriene receptor antagon... (Leggi Articolo)
- Gardasil: safety and side effects
- In a commentary published in the Canadian Medical Association Journal ( CMAJ ), Abby Lippman, an epidemiologist at McGill University in Montreal, Canada, and colleagues wrote that there is no urgent need for wide-scale cervical cancer vaccinations because deaths from the disease have been declini... (Leggi Articolo)
- Human papillomavirus vaccine safety: VAERS reports 6 months after approval of Gardasil
- On June 8th 2006, the FDA ( Food and Drug Administration ) announced the approval of Gardasil, and on June 29th the Advisory Committee on Immunizations Practices ( ACIP ) voted to recommend adding Gardasil human papillomavirus vaccine to the Centers for Disease Control's national childhood recomm... (Leggi Articolo)
- Allergies: neutrophils in lung produce histamine
- Researchers have discovered that histamine, the inflammatory compound released during allergic reactions that causes runny nose, watery eyes, and wheezing, can be produced in large amounts in the lung by neutrophils, the white blood cells that are the major component of pus. Pus, a fluid found... (Leggi Articolo)
- Treatment of pain associated with osteoarthritis: Voltaren gel
- Voltaren Gel ( Diclofenac sodium topical gel ) 1% has received FDA approval as the first topical prescription treatment that patients can apply directly to sites of pain associated with osteoarthritis. Diclofenac is a non-steroidal anti-inflammatory ( NSAID ) medication, for use in treating pa... (Leggi Articolo)
- Nrf2 gene critical for protection against septic-shock-induced death
- Disruption of a single gene, Nrf2, plays a critical role in regulating the body's innate immune response to sepsis and septic shock. A research team, led by Shyam Biswal, at the Johns Hopkins Bloomberg School of Public Health, found that the absence of Nrf2 caused a dramatic increase in morta... (Leggi Articolo)
- New treatment guidelines for pregnant women with asthma
- The National Asthma Education and Prevention Program (NAEPP) has issued the first new guidelines for managing asthma during pregnancy. The report reflects new medications that have emerged and updates treatment recommendations for pregnant women with asthma based on a systematic review of data o... (Leggi Articolo)
- Nitrosoglutathione protects against asthma
- Researchers at Duke University Medical reported that it had discovered a natural compound, nitrosoglutathione ( GSNO ), that helps keep airways open. Mice with elevated levels of GSNO were much less susceptible than normal animals to getting asthma. Moreover, animals deficient for GSNO develope... (Leggi Articolo)
- Omalizumab add-on therapy significantly reduces attacks in allergic asthma,
- Data from seven clinical studies demonstrate that in patients with severe allergic asthma who require treatment with oral corticosteroids – indicating that they have a more severe form of the disease – Xolair ( Omalizumab ), a humanized therapeutic antibody, significantly reduced the rate of seve... (Leggi Articolo)
- Treatment of severe allergic asthma: Xolair, the first monoclonal antibody approved in Europe
- European Commission has granted marketing authorization in all 25 EU member states for the novel asthma therapy Xolair ( Omalizumab ). Xolair offers a unique therapeutic approach by blocking the action of IgE, an underlying cause of symptoms in allergic disease. " Xolair represents a real a... (Leggi Articolo)
- Singulair for perennial allergic rhinitis, FDA approved
- The Fda ( Food and Drug Administration ) has approved Singulair ( Montelukast ) for the relief of symptoms of perennial allergic rhinitis ( PAR ), or indoor allergies, in adults and children six months of age and older. A convenient once-a-day tablet, Singulair has been proven to help relieve ... (Leggi Articolo)
- Omalizumab: long-term benefits for patients with severe allergic asthma
- Long-term data show that Xolair ( Omalizumab ), a first-in-class monoclonal antibody for treating severe allergic asthma, helped patients to maintain control of their disease and was safe and well-tolerated in studies lasting more than three years. Long-term control of severe allergic asthma w... (Leggi Articolo)
- Asthma, allergies may reduce risk of brain cancer
- A study suggests having asthma, hay fever or another allergic condition may reduce the risk of developing one fatal form of brain cancer. New evidence for this relationship is found in the normal variation of two genes. “ Variations in certain genes may make a person more prone to develop a... (Leggi Articolo)
- Products derived from bees: serious adverse reactions
- Substances derived from bees include bee pollen, royal jelly and propolis. Bee pollen can come from a variety of plants and may include pollen to which people are commonly allergic ( e.g., ragweed pollen ). Royal jelly consists of the secretions of the hypopharyngeal and mandibular glands of wo... (Leggi Articolo)
- Novartis, new products portfolio
- Novartis has a comprehensive portfolio of cardiovascular products both in the market ( Diovan and Lotrel ) as well as in development ( such as LAF237 and SPP100 ), for the treatment of hypertension, dyslipidemia and diabetes. Other compounds in development include APP018 ( D-4F ), an oral Apo ... (Leggi Articolo)
- Steroid-resistant asthma: vitamin D3 can improve the responsiveness to steroid treatment
- Asthma patients who don't respond to steroid treatment suffer repeated asthma attacks, and are at greater risk of dying from the condition. Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment, o... (Leggi Articolo)
- Children with persistent asthma, specific asthma characteristics could help determine the type of treatment
- Researchers have identified specific asthma characteristics in children that could help determine the type of asthma treatment they will best respond to. Szefler and colleagues from the National Heart, Lung, and Blood Institute’s ( NHLBI’s ) Childhood Asthma Research and Education ( CARE ) Net... (Leggi Articolo)
- Xolair halves rate of severe exacerbations in patients at risk of life-threatening asthma attacks
- Results of a clinical study showed that Xolair ( Omalizumab ) halved the rate of severe asthma exacerbations and reduced the rate of hospital emergency visits by 44% in patients with inadequately controlled severe persistent asthma, who are at high risk of life-threatening attacks. Xolair also... (Leggi Articolo)
- Nine percent of children may outgrow their tree nut allergies
- Approximately 9% of children with an allergy to tree nuts will outgrow their allergy, including children who have previously experienced a severe allergic reaction. The study is published in the Journal of Allergy & Clinical Immunology ( JACI ). Up to this point, researchers thought that a... (Leggi Articolo)
- Intranasal flu vaccine not linked to unexpected serious risks
- Approximately 2.5 million people received the intranasal influenza vaccine the last 2 flu seasons, and a new study did not identify unexpected serious risks associated with use of this vaccine. Until the 2002-2003 influenza season, the only licensed influenza vaccine in the United States was t... (Leggi Articolo)
- Allergies: more than half the US population is sensitive to one or more allergens
- A large study found that more than fifty percent of the U.S. population tested positive to one or more allergens. The new findings, based on data from the third National Health and Nutrition Examination Survey ( NHANES III ), shows that 54.3% of individuals aged 6-59 years old had a positive s... (Leggi Articolo)
- Persistent cough treatments for children may not be the most effective
- Two reviews of previous medical studies suggest that traditional medical treatment of persistent cough may not be the most effective. One review concludes that antibiotic treatment might be useful for children with moist coughs that last more ten days. A second review suggests that children w... (Leggi Articolo)
- FDA approves Asmanex for once-daily treatment of asthma
- The FDA ( Food and Drug Administration ) has approved the use of Asmanex Twisthaler 220 mcg ( Mometasone furoate inhalation powder ) for the first-line maintenance treatment of asthma as preventive therapy in patients 12 years of age and older. Clinical studies with Asmanex have shown improv... (Leggi Articolo)
- Newborns' exposure to toxic substances could be behind sharp rises in asthma, allergies and lupus
- Exposure of fetuses and newborns to low levels of environmental poisons such as lead, mercury and dioxin, as well as nicotine and ethanol, could be behind the recent sharp rises in asthma, allergies and autoimmune disorders like lupus. The real dangers from environmental toxicants most likely ... (Leggi Articolo)
